EUVIMEDEUVIMED entdecken
Crossref

From the Publisher: Best Corporate Practices for the Biotech Industry

Keith L. Carson

BioProcessing Journal · 27.07.2026 · 6

DOI: 10.12665/j81.kcarson ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are some encouraging signs concerning the economy. We’ll know that things are improving when the big firms start to spin off companies. And the best deals will be those in which the new owners are the people who are closest to the products and technologies. As part of the deal, the divesting firm could retain certain rights or options for technologies, manufacturing, and marketing. They could also retain a certain amount of ownership in what would now be small innovative firms with people devoted to the technologies, and they could lease unused facilities to these firms instead of giving them away to people who would tear them down. And still better, would be if they returned to the very successful model of providing milestone payments when critical development goals were met...

Zitieren

APA

Carson, K. L. (2026). From the Publisher: Best Corporate Practices for the Biotech Industry. BioProcessing Journal, 6. https://doi.org/10.12665/j81.kcarson

Vancouver

Carson KL. From the Publisher: Best Corporate Practices for the Biotech Industry. BioProcessing Journal. 2026:6. doi:10.12665/j81.kcarson

BibTeX
@article{Carson2026,
  author = {Carson, Keith L.},
  title = {From the Publisher: Best Corporate Practices for the Biotech Industry},
  journal = {BioProcessing Journal},
  year = {2026},
  pages = {6},
  doi = {10.12665/j81.kcarson}
}
Kostenlos starten →